Study of Tetralogy of Fallot in Newborns
Part of Genetic & congenital, Heart & circulation clinical trials.
This trial looks at newborns with Tetralogy of Fallot, a heart condition present at birth. It aims to study the best way to treat these babies in the first month of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby is diagnosed with Tetralogy of Fallot (a heart condition that affects blood flow).
- Your baby is a newborn, 28 days old or younger.
- Your baby's birth weight is more than 2.5 kilograms (about 5.5 pounds).
- Your baby does not have other complex heart defects or genetic conditions.
- Your baby is not born prematurely (before 37 weeks).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a coordinated treatment plan for newborns with critical congenital heart disease, starting before birth and continuing after delivery. It aims to improve outcomes for babies who need two-ventricle repair surgery.
This trial tests whether a beta-blocker called propranolol can improve how well heart muscle cells work in very young babies with certain congenital heart conditions. It mainly looks at safety and how the medicine affects the heart, which could help guide future treatments.
This study tests an early, first-use version of a new pulmonary valve device for children whose own valve is not working well. It may help improve blood flow from the heart to the lungs and aims to learn how safe and effective the valve is over time.
This trial tests whether specific exercises can improve lung function in adults who had surgery for Tetralogy of Fallot (TOF), a heart condition. It may help you breathe better and feel stronger.
This study validates a new method to locate abnormal heart rhythms using ECG (a simple heart recording) in adults who had tetralogy of Fallot surgery as children. Researchers will compare the new mapping technique during a scheduled heart procedure to improve how doctors find and treat dangerous rhythms in the future.
This trial tests new surgical strategies for newborns with certain complex heart conditions. It aims to see which techniques lead to better recovery and quality of life in the first year after surgery.
Hear when a new Tetralogy of Fallot (TOF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.